SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001494650-21-000086
Filing Date
2021-07-28
Accepted
2021-07-28 07:57:31
Documents
15
Period of Report
2021-07-28
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K optn-20210728.htm   iXBRL 8-K 36399
2 EX-99.1 preliminaryrevenueandcalla.htm EX-99.1 12864
6 image_0a.jpg GRAPHIC 31041
7 optn-20210728_g1.jpg GRAPHIC 10067
  Complete submission text file 0001494650-21-000086.txt   267567

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT optn-20210728.xsd EX-101.SCH 1902
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT optn-20210728_lab.xml EX-101.LAB 25848
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT optn-20210728_pre.xml EX-101.PRE 13581
8 EXTRACTED XBRL INSTANCE DOCUMENT optn-20210728_htm.xml XML 11734
Mailing Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067
Business Address 1020 STONY HILL ROAD SUITE 300 YARDLEY PA 19067 267-364-3500
OptiNose, Inc. (Filer) CIK: 0001494650 (see all company filings)

IRS No.: 421771610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38241 | Film No.: 211119876
SIC: 2834 Pharmaceutical Preparations